Metabolic & Cardiometabolic · Gut & Microbiome

microbial indole increases GLP-1

In plain terms: Can indole, a gut-bacteria compound, boost the blood-sugar hormone GLP-1?

Leans support(Animal or laboratory evidence) Metabolic & Cardiometabolic 🐭 Non-human evidence🔬 Includes disconfirming

RefutedContestedStrong support

consensus score 0.73

Why the rating is limited: animal or laboratory evidence.

The studies that point for or against this claim are all animal or laboratory studies. They do not establish the claimed effect in people.

Before this limit: strong support. Final rating: leans support.

Yes, but shown mainly in animals and lab models, not yet proven in people.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Animal studies (Animal)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

6 support 0 contradict 1 tested null 2 mixed · 9 sources, 6 independent groups

What the evidence shows

Microbial tryptophan-derived indole has a biphasic effect on per-cell GLP-1 (acute stimulation via Kv-channel block, chronic suppression via reduced ATP) but also expands L-cell number/differentiation; indole derivatives are inversely associated with human T2D risk. Animal/mechanism-grade.

The evidence (12)

Source	Grade	Stance	Quality	Finding
Vanslette AM, Toft PB, Lund ML, Moritz T, Arora T 2023 · Eur J Pharmacol	animal	mixed	moderate	5-HT4 (downstream of indole/EC-cell axis) agonism raised colonic Gcg/GLP-1; propionate did not - GLP-1 induction is pathway-specific
Masse KE, Lu VB 2023 · Front Endocrinol	mechanism	supports	low	Narrative review: 'This review will focus on the activation mechanisms of glucagon-like peptide-1 releasing enteroendocrine cells by the three main bacterial metabolites produced in the gut: short-chain fatty acids, secondary bile acids and indoles.' No own data. Review — zero weight.
Li Q, Tan D, Xiong S, Yu K, Su Y, Zhu W 2025 · Gut Microbes	animal	supports	moderate	Pig model: time-restricted feeding elevated GLP-1 mediated by gut microbial tryptophan metabolites (indoles), linking microbial Trp catabolism to GLP-1
Rakhat Y, Banno S, Zhantleu D, Tsunekawa S, Yabe D, Seino Y, Iwasaki Y, Yada T 2026 · Nutrients	animal	tested-null	low	D-allulose stimulated endogenous GLP-1 via vagal/central routes in obese mice - corroborates gut-metabolite GLP-1 signalling axis
Hart J, Mansour H, Sawant H, Chicko M, Arthur S, Haynes J, Borthakur A 2025 · (human organoid+rat)	in-vitro	supports	moderate	Indole and Trp-metabolite supernatant raised enteroendocrine differentiation (CHGA) in human colonic organoids, boosting GLP1 capacity
Chimerel C, Emery E, Summers DK, Keyser U, Gribble FM, Reimann F 2014 · Cell Rep	in-vitro	mixed	moderate	Chimerel indole biphasic acute-up chronic-down (mouse L-cells); biphasic=mixed
Ye X, Li H, Anjum K, Zhong X, Miao S, Zheng G, Liu W, Li L 2022 · Front Immunol	mechanism	mixed	low	Narrative review: 'This review provides scientific bases for the correlation of indoles with diseases'; frames indoles as 'double-edged swords'. GLP-1 biphasic point is from cited work, not new data. Review — zero weight.
Meijerink J 2021 · Molecules	observational	tested-null	low	Review: microbial short/branched-chain fatty acids and odorant receptors on L cells stimulate GLP-1 - mechanistic plausibility for indole class
Buckley MM, O'Brien R, Brosnan E, Ross RP, Stanton C, Buckley JM, O'Malley D 2020 · (rat)	animal	supports	moderate	Indole 1mM stimulates colonic vagal afferents via GLP-1 L-cells; neural coupling. ANIMAL
Prasad R, Adu-Rutledge Y, Ziani B, Floyd JL, Ready EL, Paul S, Sheini F, Sharma R, Rosencrans RF, Li Calzi S, Sielski MS, Medawar NG, Dutta R, Johnson EB, Qi X, Bansal M, Lamendella R, Wright JR, Verma SK, Boulton ME, Stevens BR, Vander Kooi CW, Sun RC, Oudit GY, Li Q, Grant MB 2026 · Gut	animal	supports	moderate	In db/db mice, strategies that increased intestinal tryptophan absorption (engineered Lactobacillus paracasei-ACE2 or Ile-Trp dipeptide) raised indole-propionic-acid-pathway metabolites, 'boosted incretin secretion,' and restored glucose ho
Phuah P et al 2025 · bioRxiv	animal	supports	moderate	Indole stimulated GLP-1 secretion in vitro dose-dependently; improved acute glucose tolerance in mice; drove L-cell differentiation in ileal organoids/in vivo, raising L-cell density; sub-chronic dosing improved glucose tolerance/insulin se
Phuah P, Norton M, Cheng S, Roberts AG, Pirri D, Meyer L, Chung PE, Dunsterville C, Karwowski R, Lam BYH, Otsubo E, Aleksashina S, Gribble FM, Reimann F, Hanyaloglu AC, Yeo GSH, Bewick GA, Jones B, Owen B, Murphy KG 2026 · Diabetologia	animal	supports	moderate	Sub-chronic indole improved glucose tolerance + drove L-cell differentiation in diabetic mice

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.